We use cookies to ensure you get the best experience on our website. By continuing to browse, you agree to our use of cookies and our Privacy Policy
Last seen: 1 month ago
Hi, I’m Akanksha, part of the editorial team. I closely monitor pharma and overall healthcare movements to provide quick, accurate, and reliable updates for our readers.
Gaming disorder in ADHD children may rise due to negative parenting behaviors, a...
Hengrui Q1 2026 profit results remain in line with expectations as China’s top d...
US FDA approves Merck HIV pill combo Idvynso, offering a new once-daily treatmen...
India silent liver epidemic GLP-1 drugs highlight rising fatty liver risk as exp...
IICT dialysis technology cost reduction India brings affordable treatment as ind...
Gut microbiome Parkinson risk gene study shows early microbial changes in carrie...
India ammonia rule pharma impact grows as new directive shifts surplus ammonia t...
India obesity drug market pills gain momentum as rising demand and Chinese drug ...
Merck Inhibrx cancer drug deal Keytruda gains momentum as pharma rivals explore ...
Roche MS drug fenebrutinib trial deaths raise safety concerns as the company sub...
Merck Eisai cancer drug Phase 3 trial misses primary endpoint, raising concerns ...
AstraZeneca reports Ultomiris significantly reduced urine protein levels in a la...
Eli Lilly plans to acquire Boston-based Kelonia for up to $7 billion to strength...
Exports from Indore SEZ grew 10% in FY25–26, driven by strong performance from t...
Eli Lilly’s CEO stated that weight-loss drugs could reach only about half of eli...
Pharmacy startup Plazza is in discussions to raise $12–15 million from Accel, Ne...